Lexicon Pharmaceuticals | LXRX - Trade Creditors


Lexicon Pharmaceuticals reported $5.9M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Abbott USD 4.12B 183M Sep/2025
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Esperion Therapeutics USD 77.51M 2.81M Sep/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Illumina USD 240M 22M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Lexicon Pharmaceuticals USD 5.9M 4.79M Jun/2025
MacroGenics USD 5.94M 1.28M Sep/2025
MannKind USD 9.03M 1.76M Dec/2025
Merck USD 4.15B 102M Sep/2025
Moderna USD 317M 50M Dec/2025
Novartis USD 4.56B 49M Sep/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
Thermo Fisher Scientific USD 3.62B 502M Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024